JP Patent

JP2022058514A — メニン－ｍｌｌ相互作用の阻害剤

Assigned to Vitae Pharmaceuticals LLC · Expires 2022-04-12 · 4y expired

What this patent protects

【課題】メニン－ＭＬＬ相互作用を阻害する新規薬剤を提供する。【解決手段】例えば、下式の構造を有する化合物が示される。TIFF2022058514000454.tif60170【選択図】なし

USPTO Abstract

【課題】メニン－ＭＬＬ相互作用を阻害する新規薬剤を提供する。【解決手段】例えば、下式の構造を有する化合物が示される。TIFF2022058514000454.tif60170【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number
JP2022058514A
Jurisdiction
JP
Classification
—
Expires
2022-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Vitae Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.